Literature DB >> 577329

C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children.

J Ludvigsson, L G Heding.   

Abstract

Fasting serum C-peptide and total immunoreactive insulin (IRI) were determined in 38 non-diabetic children and adolescents 6-22 years old. C-peptide varied between 0.22-0.73 pmol/ml (mean +/- SD, 0.45 +/- 0.11). There was a tendency to higher values during puberty. No difference was found between subjects with or without a family history for diabetes. IRI varied between 0-31 millimcron/m1 (mean +/- SD, 11.3 +/- 6.5). The C-peptide response to glucagon was studied in 10 insulin dependent juvenile diabetics 11-19 years old, who had had measurable amounts of fasting C-peptide on some occasions during the previous years. Duration of diabetes varied between 4-12 years. A slight but significant rise in C-peptide level occurred in 3 patients. Their metabolic control estimated on the basis of daily urinalysis was "excellent" or "good". The results support the hypothesis that even trace remnants of the beta cell function may be of importance for the metabolic control in juvenile diabetes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 577329     DOI: 10.1530/acta.0.0850364

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

1.  Photopheresis at onset of type 1 diabetes: a randomised, double blind, placebo controlled trial.

Authors:  J Ludvigsson; U Samuelsson; J Ernerudh; C Johansson; L Stenhammar; G Berlin
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

2.  Newer forms of insulin.

Authors:  N J Bohannon
Journal:  West J Med       Date:  1983-07

3.  C-Peptide reserve in insulin-dependent diabetes. Comparative responses to glucose, glucagon and tolbutamide.

Authors:  R D Mirel; F Ginsberg-Fellner; D L Horwitz; E J Rayfield
Journal:  Diabetologia       Date:  1980-09       Impact factor: 10.122

4.  Residual beta cell function in insulin-dependent diabetes: evaluation by circadian determination of C-peptide immunoreactivity.

Authors:  B Canivet; M Harter; G Viot; N Balarac; B P Krebs
Journal:  J Endocrinol Invest       Date:  1980 Apr-Jun       Impact factor: 4.256

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.